Report
EUR 12.98 For Business Accounts Only

An unfavourable environment weighs on SDI.PHARM.INDS.& MLP., which sees a downgrade to Neutral

The independent financial analyst theScreener just requalified the general evaluation of SDI.PHARM.INDS.& MLP. (SA), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date October 20, 2020, the closing price was SAR 35.15 and its target price was estimated at SAR 28.13.
Underlying
Saudi Pharmaceutical Inds

Saudi Pharmaceutical Industries & Medical Appliances Corporation. Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC (SPIMACO) is a Saudi Arabia-based company engaged in the pharmaceutical industry sector. The Company is organized, together with its subsidiaries, into two business segments: the Medical and pharmaceutical production segment focuses on the manufacture, production, development and marketing of pharmaceutical raw materials and medical appliances, as well as the production of consumables medical appliances, and the Investment segment is engaged in investing activity in associates and investment in securities. The Company's product pipeline includes tablets, capsules, dry powder for suspension, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Company's manufacturing facility is located at Qassim Industrial City, about 320 kilometers north-west of Riyadh.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch